Staff

	Amy Efantis President & CEO
Global Initiatives
John Delacourt Chief Legal Officer and Vice President, Global Initiatives	Larisa Cervenakova Medical Director	George Schreiber Director Epidemiology
Brenna Raines Assistant Director Global Health Policy	Abigail Glaser Administrative Assistant
Source & International Affairs
Joshua Penrod Senior Vice President Source & International Affairs	Sonia Balboni Director Source & Standards	Alexa Wetzel Director Source Europe
Julia Fabens Assistant Director International Affairs	Brenda Norman Senior Manager Data	Diana Krueger Manager IQPP Audits
	Bobbi Stackman Coordinator Source & International Affairs
Regulatory & Quality Policy
Mary Gustafson Vice President Global Regulatory Policy	Dominika Misztela Senior Director Regulatory Policy Europe	Bill Speir Senior Director Advocacy and Regulatory Policy
Michelle Fransen Project Manager Health Initiatives	Michelle Mason Coordinator Global Regulatory Policy/ QSEAL Administrator
Public Affairs, Europe
Maarten Van Baelen Executive Director Europe	Karl Petrovsky Director Health Policy	Sándor Tóth Senior Manager Government Affairs and Health Policy
Athina Giannoutsou Manager Public Affairs	Melanie Conrads Office Manager
Public Affairs, North America
Julie Birkofer Senior Vice President Public Affairs	Tom Lilburn Senior Director Government Relations	Mat Gulick Director Global Communications
Rachel Liebe Manager Global Communications	Tim Swope Manager Government Relations	Manisha Vasudeva Communications Specialist Global Communications
	April O'Neal Executive Assistant
Finance & Operations
Gene Stroshane Senior Director Finances & Operations	Cathy Izzi Senior Director Human Resources & Administrative Services	Mike McCormick Director IT & Facilities
	Charon Smith Senior Manager Accounts Receivables/Payables

PPTA News

PPTA Repeats Appeals for Plasma Donations +

The Plasma Protein Therapeutics Association is steadfast in its mission to promote the availability of, and access to, safe and effective plasma protein therapies for patients around the world. We call on all eligible adults to donate plasma – whether you are someone recovered from COVID-19 or not, your plasma is needed to save lives, now. By donating plasma today, you are directly helping to save the lives of babies born with primary immune deficiencies, bleeding disorders, and other rare conditions, as well as patients who rely on plasma therapies in emergency and critical-care contexts.
Read More
White House Roundtable: “We’re in this Together” +

Yesterday, President Trump, senior officials within his Administration, and representatives from the plasma and blood communities agreed that plasma donation is a national imperative, recognizing how essential plasma is and urging Americans to donate their plasma. Paul Perreault, Chief Executive Officer and Managing Director of CSL Ltd. represented the CoVIg-19 Alliance, “an unprecedented partnership of world-leading companies” dedicated to the development of a hyperimmune globulin with the potential to treat people seriously impacted by COVID-19. He took the opportunity presented by participating in the White House Roundtable to issue a call for all Americans to donate plasma, even those who have not had COVID-19, and to urge the Administration to support the industry’s effort to develop a hyperimmune to combat COVID-19.
Read More
PPTA Responds to July 24 White House Executive Orders +

White House executive orders issued on July 24 calling for a “favored nations” and drug importation program are ill-advised and risk the lives of U.S. patients who rely on access to plasma protein therapies. These unique, non-interchangeable and lifesaving therapies treat patients with rare diseases such as primary immune deficiency and bleeding disorders, like hemophilia. The executive order on favored nations would use pricing schemes from countries that often do not make the PPTs used by U.S. patients available, often selecting only one representative drug in a category and artificially setting prices.
Read More
EU Health Commissioner Says Plasma Donation is “More Important Than Ever” +

The Plasma Protein Therapeutics Association (PPTA) welcomes EU Health Commissioner Kyriakides’ recognition of the importance of plasma donation in her observance yesterday of World Blood Donor Day. By noting plasma’s role in the manufacture of plasma-derived medicinal therapies (PDMPs) for people with a range of life-challenging diseases, as well as its potential role in treating people with COVID-19, Commissioner Kyriakides rightly notes that “donating plasma is therefore now more important than ever.”
Read More

1
2
3

› ‹

Mission Video

Learn more about the need for plasma donors, plasma donation, and how you can save and improve lives. Find a Donation Center.

"How Is Your Day?" is an initiative to raise awareness of the unique nature of plasma protein therapies and the value they provide to patients. It aims to inform and educate decision makers and the general public worldwide.

Get involved and follow "How Is Your Day?" on social media @HIYDglobal

Media and Information

Advocacy

Copyright © 2020 PPTA. All rights reserved. (202) 789-3100

Terms of Use | Privacy Statement | Sitemap